Enikő Jókai

3PUBLICATIONS
16CO-AUTHORS
Pharmaceutical delivery technologiesMolecular targetsPharmacogenomics
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (3)

|Mar 25, 2026
Phase 3 study comparing the efficacy and safety of proposed biosimilar RGB-14-P with denosumab in postmenopausal women with osteoporosis: results from the transition (switch) phase.

Serge Ferrari, Lothar Seefried, Dénes Páll

|Feb 18, 2026
A Randomized Phase 1 Study Comparing the PK, PD, Safety, and Immunogenicity of Proposed Biosimilar RGB-14-X and Denosumab in Healthy Adult Males.

Emmanuel Biver, Jean-Jacques Body, Ashwin Sachdeva

|Oct 26, 2018
The first biosimilar approved for the treatment of osteoporosis: results of a comparative pharmacokinetic/pharmacodynamic study.

I Takács, E Jókai, D E Kováts

Pageof 1